PROJECTS
New Zealand National Health Products Bill Regulatory Assessment
The problem
Small natural health companies in New Zealand were concerned that a new Natural Health and Supplementary Products Bill would reduce consumer choice, increase prices, and potentially put them out of business due to the cost associated with the new regulation.
How we helped
Castalia undertook a cost-benefit analysis to identify whether the regulatory regime was economically justified. Our conclusion was that some elements were justified, however we found that the regime did not meet the criteria for risk-proportionate and growth-focused regulation. We identified possible alternative that were low-cost and would meet these criteria.
Impact
Our client, a participant in the natural health products sector, used the report to present their case to the New Zealand government. The Natural Health and Supplementary Products Bill was not reinstated after it lapsed, and so did not become law.
Our team
No posts found.
How can we help you?
How can we help you?
WASHINGTON, DC
+1 (202) 466-6790
1747 Pennsylvania Avenue NW, Suite 1200
United States of America
SYDNEY
+61 (2) 9231 6862
Suite 19.01, Level 19, 227 Elizabeth Street
Australia
AUCKLAND
+64 (4) 913 2800
Sinclair House, 3 Glenside Crescent
New Zealand
WELLINGTON
+64 (4) 913 2800
Level 2, 88 The Terrace
New Zealand
PARIS
+33 (0)1 85 64 10 22
3B Rue Taylor
France
BOGOTÁ
+57 (1) 508 5794
Calle 81 #11-08, Piso 5, Oficina 5-121
Colombia
Thinking for a better world.
WASHINGTON, DC
+1 (202) 466-6790
1747 Pennsylvania Avenue NW, Suite 1200
United States of America
SYDNEY
+61 (2) 9231 6862
Suite 19.01, Level 19, 227 Elizabeth Street
Australia
AUCKLAND
+64 (4) 913 2800
74D France Street, Newton South
New Zealand
WELLINGTON
+64 (4) 913 2800
Level 2, 88 The Terrace
New Zealand
PARIS
+33 (1) 73 44 26 97
6 Rue Duret
France
BOGOTÁ
+57 (1) 508 5794
Calle 81 #11-08, Piso 5, Oficina 5-127
Colombia
Thinking for a better world.